Addressing Unmet Medical Needs in NeuroPsychiatry Through Precision Neuroscience
Our Mission
ReST develops breakthrough therapies to treat complex neurological and psychiatric disorders. Our lead program, RST-01 is focused on treatment for Post Traumatic Stress Disorder (PTSD)
Our Team

Patrick Tricoli, PharmD, MBA
Chief Executive Officer

Gilles Rubinstenn, PhD, MBA
Chairman of the Board & Chief Innovation Officer

Reina Benabou, MD, PhD
Chief Medical Officer

Anthony Franco, J.D.
Chief Operating Officer
Our Partners






